TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-β/Smads and ERK1/2 signaling pathways
Xiaocheng Cheng(The Affiliated Yongchuan Hospital of Chongqing Medical University), Dongying Zhang(Huaian First People’s Hospital), Liyou Wang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Guanglei Chang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Guoxing Li(Wenzhou Medical University), Lei Gao(Fujian Medical University), Shu Qin(Shanxi Agricultural University), Xuesong Wen(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 44
Related Papers
Prognostic value of NT-proBNP in patients with severe COVID-19
|Respiratory Research|2020|307
Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy
|Journal of Molecular Medicine|2018|106
TNAP inhibition attenuates cardiac fibrosis induced by myocardial infarction through deactivating TGF-β1/Smads and activating P53 signaling pathways
|Cell Death and Disease|2020|93
A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study
|Journal of Diabetes and its Complications|2008|75
lncRNA HOTAIR Protects Myocardial Infarction Rat by Sponging miR-519d-3p
|Journal of Cardiovascular Translational Research|2019|50